MedTrace Logo

Finnish Tennis Elbow Trial Pilot Study

NCT02425982 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 99

Last updated 2025-01-07

No results posted yet for this study

Summary

The study aims to investigate the natural course and the results of operative treatment of chronic tennis elbow (TE). Chronic is defined as symptoms having lasted for more than a year. The investigators will also study the effect of pain catastrophising on the subjective outcome, the patient acceptable symptomatic state and the response shift phenomenon in TE. The study will also ascertain the feasibility of a multi-center randomised, controlled trial (RCT), and test and refine the co-operation and interaction of the planned RCT centers.

Conditions

  • Tennis Elbow

Interventions

PROCEDURE

Operative treatment

The exact treatment depends on the surgeon, but the majority are anticipated to be elbow arthroscopy followed by either arthroscopic or open extensor carpi radialis brevis release.

PROCEDURE

Conservative treatment

The treatment consists of physiotherapy, activity modification, pain medication and watchful waiting. Injection therapies will be avoided.

Sponsors & Collaborators

  • University of Helsinki

    lead OTHER

Principal Investigators

  • Teppo LN Järvinen, MD, professor · Helsinki University, Helsinki University Central Hospital

  • Tuomas Lähdeoja, MD · Helsinki University, Helsinki University Central Hospital

  • Mikko Salmela, MD · Helsinki University, Helsinki University Central Hospital

  • Teemu Karjalainen, MD, PhD · Central Finland Central Hospital

  • Pirjo Toivonen, coordinator · Helsinki University, Hatanpää Hospital

Eligibility

Min Age
35 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-08-31
Primary Completion
2018-03-15
Completion
2018-03-15

Countries

  • Finland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02425982 on ClinicalTrials.gov